Drug Topics

DECEMBER 1, 2023

A new study found that glucose monitoring devices can help significantly improve the sleep of both parents and children.

503

503

Pharmacy Times

DECEMBER 1, 2023

Many workers don’t advertise their level of loneliness, nor do they know the impact of loneliness on their well-being.

145

145

Drug Topics

DECEMBER 1, 2023

A Q&A with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, director of education and training in diabetes technology at the Cleveland Clinic.

281

281

STAT

DECEMBER 1, 2023

Pfizer on Friday said it was stopping development of a twice-daily oral obesity medication after an underwhelming clinical trial, a blow to the company’s efforts to compete in the booming field of weight-loss medications. The medicine, danuglipron, met its primary target in a placebo-controlled Phase 2b trial, leading to a statistically significant amount of weight lost, the company said.

141

141

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 1, 2023

The risks of poor health, more health care needs, and gynecological cancer are significantly increased in patients with disabilities.

247

247

STAT

DECEMBER 1, 2023

When Jennifer Case was living in Los Angeles in her early 30s, she was hospitalized 11 times. She had been born with two rare heart abnormalities, Ebstein anomaly and Wolff-Parkinson-White syndrome. Her parents were told that she probably wouldn’t live.

Hospitals 140

Hospitals 140

Fierce Healthcare

DECEMBER 1, 2023

Analysts say a Cigna-Humana merger is likely to face major antitrust opposition.

137

137

Pharmacy Times

DECEMBER 1, 2023

Patients with this genetic variant have impaired neuronal excitability, a trait that has been linked to malfunctional synapses.

139

139

STAT

DECEMBER 1, 2023

Children with drug-resistant epilepsy who are Black or insured through Medicaid may be less likely than white and privately insured patients to receive surgical treatments that can end or minimize their seizures and extend their lives, according to new research being presented Monday at the American Epilepsy Society’s annual meeting in Orlando, Fla.

Insurance 137

Insurance Hospitals 137

Pharmacy Times

DECEMBER 1, 2023

Iberzaplstat was non-inferior to standard of care vancomycin, was safe and tolerable, and will advance into a phase 3 trial.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

DECEMBER 1, 2023

After weeks of anticipation, the U.S. Supreme Court on Monday will hear arguments to decide the fate of a controversial bankruptcy deal in which the owners of Purdue Pharma would contribute up to $6 billion in exchange for immunity from further lawsuits. The company was accused of downplaying the risks of OxyContin and improperly persuading physicians to prescribe the addictive painkiller.

Immunization 135

Immunization 135

Pharmacy Times

DECEMBER 1, 2023

Investigators believe lowering cholesteryl ester levels could help prevent brain damage and behavioral changes, reducing the risk of Alzheimer disease.

132

132

PharmaVoice

DECEMBER 1, 2023

IDEA Pharma just released its Digital Innovation Index. Here are the top companies they identified and some of the standout advances the industry made.

130

130

Pharmacy Times

DECEMBER 1, 2023

Following acoustic stimulation intervention, many patients experienced a reduction in neurobehavioral symptoms.

132

132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

DECEMBER 1, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Today we talk about Pfizer’s obesity woes, how J&J is leaning heavily into artificial intelligence, chat about how ADCs are having a heyday, and ponder the zombie microcap.

FDA 126

FDA 126

Pharmacy Times

DECEMBER 1, 2023

Further research of these mechanisms could be significant in developing future strategies to disrupt the viral persistence in individuals living with HIV.

130

130

STAT

DECEMBER 1, 2023

One of the hardest parts about getting an X-ray or a CT scan is the wait. Sometimes it takes days, or even weeks, for medical imaging results to be analyzed by a radiologist, transferred to a primary doctor, and then delivered to the patient — good news or bad. Today, that hand-wringing delay has been nearly eliminated. In 2021, provisions from the 21st Century Cures Act kicked in that require health centers to provide patients with access to their health information on request — i

122

122

Pharmacy Times

DECEMBER 1, 2023

Although involvement of a cardiologist for heart failure has been associated with reduced rates of in-hospital mortality, not all patients see a cardiologist when hospitalized, according to the investigators.

Hospitals 123

Hospitals 123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

DECEMBER 1, 2023

FDA starts review of Padcev/Keytruda for bladder cancer Phil.

FDA 119

FDA 119

Pharmacy Times

DECEMBER 1, 2023

Marlo Blazer, PharmD, BCOP, discusses the collaborative nature of the pharmacist's role within the oncology care team.

122

122

pharmaphorum

DECEMBER 1, 2023

How to advance more late-stage neuroscience drugs to regulatory approval Mike.

116

116

European Pharmaceutical Review

DECEMBER 1, 2023

AbbVie has agreed to acquire ImmunoGen and its first-in-class antibody-drug conjugate (ADC) ELAHERE ® (mirvetuximab soravtansine-gynx), for a total of approximately $10.1 billion. The antibody-drug conjugate is the first to be approved for platinum-resistant ovarian cancer (PROC) and show meaningful survival benefit for this form of the disease. As a folate receptor alpha (FRα) with a maytansinoid payload DM4, a potent tubulin inhibitor, the biologic medicine offers expansion opportunities in e

FDA 116

FDA 116

PharmExec

DECEMBER 1, 2023

How to build a loyal audience of brand evangelists.

115

115

STAT

DECEMBER 1, 2023

WASHINGTON — On its face, a minor policy to make sure Medicare pays hospitals the same as physician offices to administer medications has broad, bipartisan support from think tanks, stakeholders, and academics. But Republicans in the House and Senate are divided over the issue, creating a major obstacle to passage anytime soon. House Republicans had hoped to use a small cut to hospitals’ Medicare payments to help finance a raft of health policy that’s set to expire in Januar

Hospitals 114

Hospitals Packaging 114

PharmExec

DECEMBER 1, 2023

Artificial intelligence is making it quicker to get drug candidates to the clinic, but it isn’t addressing the fundamental need to marry the right candidate and the right target to the right disease.

115

115

STAT

DECEMBER 1, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

112

112

pharmaphorum

DECEMBER 1, 2023

Cybin preps for ph3 as psychedelic clears depression trial Phil.

111

111

STAT

DECEMBER 1, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to promenade with the official mascots, tidy up the leafy grounds, and maybe have a listening party with Mrs. Pharmalot. The rotation will likely include this , this , this and this.

Hospitals 110

Hospitals 110

pharmaphorum

DECEMBER 1, 2023

MSD, Amgen back patient data specialist Culmination Bio Phil.

106

106

STAT

DECEMBER 1, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right.  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

108

108

Drug Store News

DECEMBER 1, 2023

Giant is kicking off free virtual well-being classes featuring festive board ideas throughout December.

106

106

Fierce Healthcare

DECEMBER 1, 2023

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry players look to expand their businesses and gain a competitive edge. | A $10 billion Missouri health system merger, Virgin Pulse and HealthComp's $3 billion combination and more merger and acquisition news from the month of November.

105

105

The Checkup by Singlecare

DECEMBER 1, 2023

For people with Type 2 diabetes, Ozempic is a game-changer: This FDA-approved drug not only lowers blood sugar but can also help people lose weight. Lower blood sugar and weight loss can lead to better health and wellness outcomes for people with diabetes, who are at a higher risk for heart disease, stroke, kidney failure, and vision loss. One of the ways Ozempic (semaglutide) and other GLP-1 receptor agonists work is by decreasing appetite.

Packaging 105

Packaging Compounding FDA 105